サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1666164

トロカールの世界市場：2025年～2033年

Global Trocars Market - 2025-2033

出版日
ページ情報
英文 176 Pages
納期
即日から翌営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.82円
トロカールの世界市場：2025年～2033年
出版日: 2025年02月24日
発行: DataM Intelligence
ページ情報: 英文 176 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

糖尿病、がん、心臓病、脳卒中、胃腸障害、肝臓疾患、肥満などの慢性疾患の有病率の増加は、トロカール市場の重要な促進要因です。これらの疾患は外科的介入を必要とすることが多く、腹腔鏡手術のような低侵襲手術に不可欠なツールであるトロカールの需要増につながっています。

トロカールは、様々な慢性疾患に伴う合併症に対処する手術で一般的に使用されています。慢性閉塞性肺疾患（COPD）では、肺活量減少や肺移植のような処置のための胸腔鏡検査でトロカールが使用されます。慢性腎臓病（CKD）では、トロカールは低侵襲の腎移植や腎摘出術を支援します。例えば、2024年の米国肺協会によると、COPDは米国で約1,170万人の成人に罹患し、年間数十万件の救急外来受診と推定500億米ドルのヘルスケアコストにつながります。COPDには慢性気管支炎や肺気腫などの疾患が含まれます。2022年には、米国の成人の4.6％がCOPDと診断されました。

さらに、慢性疾患に罹患しやすい高齢者人口の増加も外科手術の需要を促進し、トロカール市場を拡大すると予想されています。

トロカールの使用に伴う合併症のリスクは、トロカール市場の大きな抑制要因になると予想されます。トロカールは安全に設計されていますが、不適切な使用や設置は血管、臓器、神経などの周辺組織の損傷につながる可能性があります。このような合併症は、外科処置の追加、回復時間の長期化、ヘルスケアコストの上昇を招く可能性があり、これらすべてが病院や外科医がトロカールを採用したり、使用を増やしたりすることを躊躇させる要因となります。

当レポートでは、世界のトロカール市場について調査し、市場の概要とともに、製品タイプ別、用途別、エンドユーザー別、地域別動向、競合情勢、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 調査手法と範囲

第2章 定義と概要

第3章 エグゼクティブサマリー

第4章 市場力学

  • 影響要因
    • 促進要因
    • 抑制要因
    • 機会
  • 影響分析

第5章 戦略的洞察と業界の展望

  • 市場のリーダーと先駆者
  • CXOの視点
  • 最新の開発とブレークスルー
  • ケーススタディ/進行中の調査
  • 規制と償還の情勢
  • ポーターのファイブフォース分析
  • サプライチェーン分析
  • 特許分析
  • SWOT分析
  • アンメットニーズとギャップ
  • 市場参入と拡大のための推奨戦略
  • シナリオ分析ベストケース、ベースケース、ワーストケースの予測
  • 価格分析と価格動向
  • キーオピニオンリーダー

第6章 製品タイプ別

  • ブレードレストロカール
  • ブレード付きトロカール
  • ディスポーザブルトロカール
  • 再利用型トロカール
  • 光学トロカール
  • 鈍角トロカール
  • その他

第7章 用途別

  • 一般外科
  • 婦人科手術
  • 泌尿器科手術
  • 小児外科
  • その他

第8章 エンドユーザー別

  • 病院
  • 外来手術センター
  • その他

第9章 地域別

  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • スペイン
    • イタリア
    • その他
  • 南米
    • ブラジル
    • アルゼンチン
    • その他
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • 韓国
    • その他
  • 中東・アフリカ

第10章 競合情勢

第11章 企業プロファイル

  • Conmed Corporation
  • The Cooper Companies Inc
  • Teleflex Incorporated
  • Medtronic Plc
  • B. Braun Medical Inc
  • JOHNSON &JOHNSON
  • Laprosurge
  • Purple Surgical
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • Peters Surgical

第12章 付録

目次
Product Code: PH1315

The global trocars market reached US$ 812.33 million in 2024 and is expected to reach US$ 1,417.87 million by 2033, growing at a CAGR of 6.4% during the forecast period 2025-2033.

A trocar is a surgical tool used to create access to body cavities during various medical procedures. Trocars are most commonly used in laparoscopic or minimally invasive surgeries, where smaller incisions are preferred to reduce recovery time, minimize scarring, and decrease the risk of infection. These tools are crucial in surgeries like laparoscopy, arthroscopy, and certain types of endoscopy, as they enable doctors to perform complex procedures with minimal disruption to the body.

It's typically made of a sharp, pointed device, often steel, which is attached to a hollow tube or cannula. This allows surgeons to puncture the body's tissue safely, providing a pathway for inserting other tools, such as cameras or surgical instruments, into the body.

Market Dynamics: Drivers & Restraints

Rising Prevalence of Chronic Diseases

The increasing prevalence of chronic diseases, such as diabetes, cancer, heart disease, stroke, gastrointestinal disorders, liver illnesses, and obesity, is a significant driver for the trocars market. These conditions often necessitate surgical interventions, leading to a higher demand for trocars, which are essential tools in minimally invasive procedures like laparoscopy.

Trocars are commonly used in surgeries that address complications associated with various chronic diseases. In chronic obstructive pulmonary disease (COPD), trocars can be used during thoracoscopy for procedures like lung volume reduction or lung transplantation. In chronic kidney disease (CKD), trocars assist in minimally invasive kidney transplants or nephrectomies. For instance, according to the American Lung Association in 2024, COPD affects approximately 11.7 million adults in the United States and results in hundreds of thousands of emergency department visits and an estimated $50 billion in healthcare costs annually. COPD includes conditions such as chronic bronchitis and emphysema. In 2022, 4.6% of adults in the U.S. were diagnosed with COPD.

Furthermore, the rising geriatric population, which is more susceptible to chronic diseases, is also expected to drive the demand for surgical procedures, thereby expanding the trocars market.

Risk of Complications

The risk of complications associated with trocar use is expected to be a significant restraint for the trocar market. Although trocars are designed to be safe, improper use or placement can lead to injury to surrounding tissues, such as blood vessels, organs, or nerves. These complications can result in additional surgical procedures, longer recovery times, and higher healthcare costs, all of which can deter hospitals and surgeons from adopting or increasing their use of trocars.

Segment Analysis

The global Trocars market is segmented based on product type, application, end-user, and region.

Product Type:

Disposable trocars segment is expected to dominate the global trocars market share

The disposable trocars segment is expected to dominate the trocars market due to several factors. These trocars are increasingly important in laparoscopic and diagnostic laparoscopy procedures. They are favored for their cost-effectiveness, user-friendliness, and enhanced safety compared to reusable options. Because they are disposable, each surgery can be set up quickly and easily while maintaining sterility, lowering the risk of infection, and requiring no reprocessing.

The convenience they offer, along with the elimination of sterilization needs and reduced risk of cross-contamination, further drives their growth. This aligns with the increasing focus on infection control measures and the rising demand for single-use surgical instruments.

Geographical Analysis

North America is expected to hold a significant position in the global trocars market share

North America's leading position in the trocars market is expected to continue, driven by several factors. The region boasts a strong healthcare system, significant healthcare spending, and a considerable presence of major companies in the field. North America has been quick to embrace advanced surgical technologies, with a growing trend towards minimally invasive procedures.

The rising rates of chronic conditions like cancer, lung diseases, diabetes, cardiovascular diseases, and obesity are also increasing the need for surgical interventions that utilize trocars. For instance, according to the National Institute of Health in 2023, primary spontaneous pneumothorax mainly occurs at 20-30 years of age. The incidence of PSP in the United States is 7 per 100,000 men and 1 per 100,000 women per year. Trocars are utilized in the treatment of primary spontaneous pneumothorax (PSP) during video-assisted thoracoscopic surgery (VATS). This data indicates a strong correlation between the increasing prevalence of lung diseases and the growth of the trocars market in North America.

Additionally, the strategic activities of market players, such as introducing new products, contribute to market growth in the region.

Competitive Landscape

The major global players in the trocars market include Conmed Corporation, The Cooper Companies Inc, Teleflex Incorporated, Medtronic Plc, B. Braun Medical Inc, JOHNSON & JOHNSON, Laprosurge, Purple Surgical, Shenzhen Mindray Bio-Medical Electronics Co., Ltd. and Peters Surgical among others.

Why Purchase the Report?

  • Pipeline & Innovations: Reviews ongoing clinical trials, and product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
  • Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
  • Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
  • Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
  • Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
  • Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
  • Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
  • Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
  • Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
  • Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
  • Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
  • Post-market Surveillance: Uses post-market data to enhance product safety and access.
  • Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The Global Trocars Market report delivers a detailed analysis with 60+ key tables, more than 50 visually impactful figures, and 176 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2023

  • Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
  • Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
  • Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
  • Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
  • Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
  • Supply Chain: Distribution and Supply Chain Managers.
  • Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
  • Academic & Research: Academic Institutions.

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Product Type
  • 3.2. Snippet by Application
  • 3.3. Snippet by End-User
  • 3.4. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Rising Prevalence of Chronic Diseases
    • 4.1.2. Restraints
      • 4.1.2.1. Risk of Complications
    • 4.1.3. Opportunity
  • 4.2. Impact Analysis

5. Strategic Insights and Industry Outlook

  • 5.1. Market Leaders and Pioneers
    • 5.1.1. Emerging Pioneers and Prominent Players
    • 5.1.2. Established leaders with largest selling Brand
    • 5.1.3. Market leaders with established Product
  • 5.2. CXO Perspectives
  • 5.3. Latest Developments and Breakthroughs
  • 5.4. Case Studies/Ongoing Research
  • 5.5. Regulatory and Reimbursement Landscape
    • 5.5.1. North America
    • 5.5.2. Europe
    • 5.5.3. Asia Pacific
    • 5.5.4. Latin America
    • 5.5.5. Middle East & Africa
  • 5.6. Porter's Five Force Analysis
  • 5.7. Supply Chain Analysis
  • 5.8. Patent Analysis
  • 5.9. SWOT Analysis
  • 5.10. Unmet Needs and Gaps
  • 5.11. Recommended Strategies for Market Entry and Expansion
  • 5.12. Scenario Analysis: Best-Case, Base-Case, and Worst-Case Forecasts
  • 5.13. Pricing Analysis and Price Dynamics
  • 5.14. Key Opinion Leaders

6. By Product Type

  • 6.1. Introduction
    • 6.1.1. Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 6.1.2. Market Attractiveness Index, By Product Type
  • 6.2. Bladeless Trocars*
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 6.3. Bladed Trocars
  • 6.4. Disposable Trocars
  • 6.5. Reusable Trocars
  • 6.6. Optical Trocars
  • 6.7. Blunt Trocars
  • 6.8. Others

7. By Application

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 7.1.2. Market Attractiveness Index, By Application
  • 7.2. General Surgery*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Gynecological Surgery
  • 7.4. Urological Surgery
  • 7.5. Pediatric Surgery
  • 7.6. Others

8. By End-User

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 8.1.2. Market Attractiveness Index, By End-User
  • 8.2. Hospitals*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Ambulatory Surgical Centers
  • 8.4. Others

9. By Region

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 9.1.2. Market Attractiveness Index, By Region
  • 9.2. North America
    • 9.2.1. Introduction
    • 9.2.2. Key Region-Specific Dynamics
    • 9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.2.6.1. U.S.
      • 9.2.6.2. Canada
      • 9.2.6.3. Mexico
  • 9.3. Europe
    • 9.3.1. Introduction
    • 9.3.2. Key Region-Specific Dynamics
    • 9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.3.6.1. Germany
      • 9.3.6.2. U.K.
      • 9.3.6.3. France
      • 9.3.6.4. Spain
      • 9.3.6.5. Italy
      • 9.3.6.6. Rest of Europe
  • 9.4. South America
    • 9.4.1. Introduction
    • 9.4.2. Key Region-Specific Dynamics
    • 9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.4.6.1. Brazil
      • 9.4.6.2. Argentina
      • 9.4.6.3. Rest of South America
  • 9.5. Asia-Pacific
    • 9.5.1. Introduction
    • 9.5.2. Key Region-Specific Dynamics
    • 9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.5.6.1. China
      • 9.5.6.2. India
      • 9.5.6.3. Japan
      • 9.5.6.4. South Korea
      • 9.5.6.5. Rest of Asia-Pacific
  • 9.6. Middle East and Africa
    • 9.6.1. Introduction
    • 9.6.2. Key Region-Specific Dynamics
    • 9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

10. Competitive Landscape

  • 10.1. Competitive Scenario
  • 10.2. Market Positioning/Share Analysis
  • 10.3. Mergers and Acquisitions Analysis

11. Company Profiles

Key Market Players

  • 11.1. Conmed Corporation*
    • 11.1.1. Company Overview
    • 11.1.2. Product Portfolio
      • 11.1.2.1. Product Description
      • 11.1.2.2. Product Key Performance Indicators (KPIs)
      • 11.1.2.3. Historic and Forecasted Product Sales
      • 11.1.2.4. Product Sales Volume
    • 11.1.3. Financial Overview
      • 11.1.3.1. Company Revenue's
      • 11.1.3.2. Geographical Revenue Shares
      • 11.1.3.3. Revenue Forecasts
    • 11.1.4. Key Developments
      • 11.1.4.1. Mergers & Acquisitions
      • 11.1.4.2. Key Product Development Activities
      • 11.1.4.3. Regulatory Approvals etc.
    • 11.1.5. SWOT Analysis
  • 11.2. The Cooper Companies Inc
  • 11.3. Teleflex Incorporated
  • 11.4. Medtronic Plc
  • 11.5. B. Braun Medical Inc
  • 11.6. JOHNSON & JOHNSON
  • 11.7. Laprosurge
  • 11.8. Purple Surgical
  • 11.9. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • 11.10. Peters Surgical
  • Similar data will be provided for each market player.

LIST NOT EXHAUSTIVE

12. Appendix

  • 12.1. About Us and Services
  • 12.2. Contact Us